China Biologic Products, Inc. (NASDAQ:CBPO) Under Analyst Spotlight

Cornelia Mascio
Ottobre 13, 2017

Davidson Kempner Management Limited Partnership owns 110,000 shares. Sensata Technologies Hldg Nv now has $8.33B valuation. State Street Corporation invested in 12,418 shares. Given that liquidity is king in short-term, GERN is a stock with 159.18 million shares outstanding that normally trades 20.79% of its float. First Merchants Corporation (FRME) has risen 59.72% since October 10, 2016 and is uptrending. It has underperformed by 43.75% the S&P500. (NASDAQ:CBPO). Fmr Ltd Liability Company holds 0.03% in China Biologic Products Holdings, Inc. They expect $1.30 earnings per share, up 28.71% or $0.29 from last year's $1.01 per share. CBPO's profit would be $39.98 million giving it 16.57 P/E if the $1.30 EPS is correct.

08/08/2016 - China Biologic Products, Inc. had its "buy" rating reiterated by analysts at Jefferies.

About 13,846 shares traded.

Axa reported 0.05% of its portfolio in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) has declined 1.48% since October 12, 2016 and is downtrending. It has underperformed by 18.18% the S&P500. Therefore 27% are positive. (NASDAQ:WETF) rating on Friday, July 28. The company was downgraded on Wednesday, October 7 by Citigroup. The company was upgraded on Monday, January 9 by RBC Capital Markets. As per Friday, September 15, the company rating was maintained by Cowen & Co. The 6 months bearish chart indicates high risk for the $2.65 billion company. Northland Capital maintained WisdomTree Investments, Inc.

Investors sentiment decreased to 1.28 in 2017 Q2. Its down 0.06, from 1 in 2017Q1. 11 funds opened positions while 19 raised stakes. Synovus Finance reported 30,726 shares.

CHINA BIOLOGIC SHS shares had a trading volume of 1,360 by the end of trading on Wednesday. Wells Fargo And Mn invested in 113 shares or 0% of the stock. Vontobel Asset Mgmt, New York-based fund reported 50,861 shares. Brown Advisory Inc holds 70,276 shares or 0.02% of its portfolio. Cornerstone Advsrs stated it has 0.02% of its portfolio in Sensata Technologies Holding N.V. (NYSE:ST). York Cap Management Ltd Liability Corp owns 80,229 shares for 0.19% of their portfolio. Fifth Third Bankshares holds 10,482 shares or 0% of its portfolio. Prudential owns 4,280 shares.

Investors sentiment decreased to 0.65 in Q2 2017.

Traders are a little more bullish on CHINA BIOLOGIC SHS recently at least if you consider the decrease in short interest. 11 funds opened positions while 34 raised stakes. Moreover, Ameriprise Financial has 0.01% invested in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) for 44,330 shares. Industries Capital Prns Ltd Liability Com has 278,407 shares. Nordea Invest Mngmt holds 0% of its portfolio in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) for 101,900 shares. Bnp Paribas Arbitrage Sa stated it has 10 shares or 0% of all its holdings. Standard Life Ltd reported 0.05% of its portfolio in China Biologic Products Holdings, Inc. (NASDAQ:CBPO) is a huge mover today! (CBPO) exchanged hands at an unexpectedly high level of 0.27 million shares over the course of the day. On Monday, October 12 the stock rating was upgraded by Janney Capital to "Buy". Manning & Napier Llc reported 71,755 shares or 0.07% of all its holdings.

Among 2 analysts covering China Biologic Products (NASDAQ:CBPO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. The company experienced a fall in short interest between August 31, 2017 and September 15, 2017 of -5.23%. The firm has "Buy" rating by Jefferies given on Monday, June 12. Jefferies maintained it with "Buy" rating and $12800 target in Thursday, August 3 report. Jefferies maintained China Biologic Products Holdings, Inc. (NASDAQ:CBPO) on Friday, September 4 with "Buy" rating.

Since May 8, 2017, it had 0 insider buys, and 1 insider sale for $873,638 activity. Liu Zhijing CBPO sold 7,500 shares worth $873,638.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE